Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Archived press releases are made available for informational purposes only. Press releases may contain certain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Archived press releases are current only as of the date of issue and BioPharmX assumes no obligation to update information contained in archived press releases.
Mar 4, 2019
Company anticipates announcing topline efficacy and safety results in July 2019
Feb 4, 2019
Dr. R. Todd Plott, developer of SOLODYN™, ZIANA™, and NORITATE™, becomes company's third independent director